TRIM21 and neonatal lupus erythematosus: Meanwhile, it has been shown that mothers with anti-SS-A/Ro and anti-SS-B/La antibodies had an increased risk of heart complications in neonatal lupus, with the most clinically significant manifestation associated with positive anti-Ro52 being the development of CHB.